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Objective: Vascular extremity injuries can be a signiﬁcant burden on a patient’s long-term quality of life. Currently, no
limb-speciﬁc surveys have been used to quantify the relation between injury pattern and the resultant physical or psy-
chological impact. The objective of this study was to validate the use of the Short Musculoskeletal Function Assessment
(SMFA) in the setting of extremity vascular injury.
Methods: The Joint Theater Trauma Registry was queried and ﬁltered for U.S. troops with an extremity vascular injury
isolated to a single limb. Injury andmanagement data were obtained, and the SMFAwas administered after patient contact
and consent. Validity was analyzed by characterization of SMFA score distribution, correlation with 36-Item Short Form
Health Survey (SF-36) scores, and assessment of its discriminative capability to external measures of injury severity (ie,
Injury Severity Score [ISS], Mangled Extremity Severity Score [MESS], and Medicare Part A disability qualiﬁcation).
Results: At mean follow-up of 5 years, 164 patients (median age, 25 years; interquartile range, 22-31 years) completed
both surveys. The overall SMFA Dysfunction Index was 24.8 6 15.2 (range, 0-78; skewness, 0.60; ﬂoor/ceiling effect,
0%-1.2%; and nonresponse, 0%), and the overall Bother Index was 29.46 20.2 (range, 0-96; skewness, 0.58; ﬂoor/ceiling
effect, 0%-4.3%; and nonresponse, 0.6%). SF-36 physical component summary scores correlated inversely with the
Dysfunction Index (r [ L0.64; P < .01), whereas mental component summary scores correlated inversely with the
Bother Index (r[L0.59; P < .01). No difference was found in reported scores between those considered severely injured
(ISS > 15) and those not severely injured (ISS # 15). However, those with mangled extremities (MESS $ 7) reported
higher Dysfunction and Bother indices than those with lower scores (P < .05). In addition, patients considered disabled
(per Medicare Part A qualiﬁcations) reported higher Dysfunction and Bother indices compared with those not considered
disabled (P < .05).
Conclusions: Use of the SMFA is validated in those with extremity vascular injuries, and it should be considered an
adjunctive tool in evaluating long-term patient outcomes. (J Vasc Surg 2014;60:1620-6.)Battleﬁeld-related injuries are associated with high rates
of extremity vascular injuries.With speciﬁc rates of extremity
vascular injuries accounting for 10% of all wartime trauma,
this injury pattern can be a major source of morbidity and
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0predeployment training, early tourniquet use, rapid trans-
port, and structured levels/echelons of care) have tempered
the mortality associated with this pattern of injury; however,
the long-term morbidity is still under investigation.2-7
To date, patient-based outcomes related to peripheral
vascular injuries have been limited to the use of generic
quality of life surveys, such as the Medical Outcomes Study
36-Item Short Form (SF-36).8,9 Whereas these surveys
offer insight into a patient’s global well-being, factors unre-
lated to a patient’s injured limb (ie, socioeconomic status,
education level, age, psychiatric disorders) can heavily in-
ﬂuence outcomes.9 As a result, the addition of a disease-
speciﬁc quality of life survey can be helpful in determining
the impact of a patient’s injury on quality of life. This, in
turn, may allow further investigation of limb-speciﬁc modi-
ﬁable factors to improve a patient’s quality of limb and life.
Currently, no disease-speciﬁc quality of life surveys
target extremity vascular injuries. The Short Musculoskel-
etal Function Assessment (SMFA) is a limb-speciﬁc quality
of life survey developed for musculoskeletal disease and
postinjury states and has potential translational value in pa-
tients with combat-related extremity vascular injuries. The
objective of this study was to validate the use of the SMFA
in a cohort of patients with battleﬁeld-related extremity
vascular injuries.
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Patient selection and data acquisition
This study was conducted under approval from the
U.S. Army Medical Research and Material Command
Institutional Review Board. The Joint Theater Trauma
Registry (JTTR) and associated Vascular Injury Initiative
(JTTR-VII) database were used.10 A query of the JTTR
was performed, identifying U.S. troops who sustained ex-
tremity vascular injury in either Operation Iraqi Freedom
(Iraq, 2003-2011) or Operation Enduring Freedom
(Afghanistan, 2001 to present). To limit potential con-
founding variables inﬂuencing recovery from extremity
vascular injury, patients who sustained concomitant head
injuries (blunt or penetrating) with severe traumatic brain
injury and ongoing neurologic and cognitive sequelae
were excluded. In addition, patients who sustained multi-
ple limb injuries, including associated primary or traumatic
amputations (nonindex limb), were also excluded. Further,
patients who had undergone initial attempts at limb
salvage, followed by secondary or delayed amputation,
were also excluded.
All patients underwent chart review for collection of
pertinent demographic and injury-speciﬁc information to
include point-of-contact assessments of injury severity:
the Injury Severity Score (ISS, 2005 revision) and the
Mangled Extremity Severity Score (MESS). Patients were
then contacted by a team of research nurse coordinators,
and informed consent was obtained. Patients consenting
to the study were administered the SF-36 and SMFA
surveys.
Survey selection
SF-36. The SF-36 generic quality of life survey con-
sists of 36 multiple-choice questions and seeks to evaluate
the overall quality of life of a patient in a wide variety of
disease and injury states.8,11,12 The SF-36 targets eight
speciﬁc scales of well-being, each with its own score. Four
scales (vitality, social functioning, role emotional, and
mental health) contribute to an encompassing mental
component summary score, and four scales (physical
functioning, role physical, bodily pain, and general health)
contribute to an overall physical component summary
score. Each raw score is scaled from 0 to 100, with higher
scores denoting better health.13
SMFA. Developed from the longer Musculoskeletal
Function Assessment, the SMFA is a limb-speciﬁc, two-
part, 46-item questionnaire designed to evaluate patients’
perceived physical and emotional difﬁculty related to their
injured or dysfunctional limb.14 Thirty-four questions are
grouped into four categories that evaluate a patient’s
dysfunction related to daily activities, emotional status,
upper extremity function, and mobility. These components
contribute to an overall Dysfunction Index (SMFA-DI).
The remaining 12 items assess how much patients are
bothered by problems across four categoriesdrecreation/
leisure, sleep/rest, work, and familydall of which
contribute to an overall Bother Index (SMFA-BI). Thesurvey uses a 5-point Likert-type response system that is
further transformed into a score ranging from 0 to 100,
with higher scores indicative of poorer function.14
Statistical analysis
Content validity was evaluated by score distribution
analysis and was described in terms of range, kurtosis,
and skew. Skew values of less than 1.0 were indicative of
a normal distribution. Floor and ceiling effects (percentage
of scores at minimum or maximum values, respectively)
were evaluated with acceptable proportions of <5%.
Nonresponse rates were also evaluated, with values <5%
as acceptable.
Construct validity was assessed by means of evaluating
relationship to other health status questionnaires (ie, the
SF-36). Survey comparisons were conducted with
Spearman r, with r $ 60.5 considered to be of moderate
clinical correlation.
Criterion validity was evaluated by the ability of the
SMFA to predictively discriminate between groups on the
basis of external measures of dysfunction. Variables
analyzed included disability qualiﬁcations and injury
severity. Dichotomous delineations were based on previ-
ously reported standards. Those qualifying for Medicare
Part A disability were considered disabled and were ulti-
mately determined by Social Security Administration ﬁeld
ofﬁce eligibility (ie, those with described injuries resulting
in disability of at least 12 months’ duration, prohibiting
full-time employment). Those remaining on full active mil-
itary duty were considered nondisabled. Those with ISS
>15 were considered severely injured, and those with
MESS $7 were considered to have severely injured ex-
tremities.15-17 Parametric continuous variables were sum-
marized by mean and standard deviation and were
compared by unpaired, two-tailed t-test.
All statistical testing was two sided, with a signiﬁcance
level of P < .05. SPSS version 20 software (IBM, Armonk,
NY) was employed for statistical analysis.
RESULTS
Demographic data. Query of the JTTR-VII resulted
in 1018 service members with extremity vascular injuries
(Fig 1). Successful contact was made in the majority of
patients (n ¼ 891; 88%). At the time of analysis, 214 pa-
tients (24%) completed both surveys. Exclusion of patients
with multiple limb injuries (including those with associated
primary amputations, n ¼ 22) and those who eventually
underwent secondary amputation (n ¼ 28) resulted in a
cohort of 164 patients with a mean follow-up of 62.4 6
23.7 months. Patients were predominantly young (median
age, 25 years; 25th-75th interquartile range, 22-31 years),
male (97.6%), and moderately to severely injured with
mean ISS of 13.7 6 7.8 and MESS of 5.4 6 1.2. Addi-
tional injury characteristics are detailed in Table I. No
differences in scores (SMFA or SF-36) were found in
comparing patients with proximal vs distal injuries, arterial
vs venous vs combined injuries, proximal vs distal injuries,
upper vs lower injuries, injuries resulting from blast vs blunt
Table I. Injury characteristics
Extremity injured
Upper (%) 45.1
Lower (%) 54.9
Mechanism of injury
Blast (%) 64.0
Blunt (%) 2.4
Penetrating (%) 33.5
Vessel injured
Arterial (%) 70.1
Venous (%) 9.8
Combined (%) 20.1
Vessel location
Proximal (%) 60.3
Distal (%) 39.6
Associated injuries
Soft tissue (%) 85.4
Bone (%) 45.7
Nerve (%) 59.1
Fig 1. Consolidated Standards of Reporting Trials (CONSORT)
diagram detailing number of combat-related extremity vascular
injuries on initial Joint Theater Trauma Registry (JTTR) query and
ﬁnal cohort after exclusion criteria.
Table II. Inverse correlation coefﬁcients between Short
Musculoskeletal Function Assessment (SMFA) indices
and 36-Item Short Form Health Survey (SF-36) scales
(all P < .001)
Dysfunction index vs
PCS BP GH PF RP
.636 .607 .524 .665 .563
MCS VT RE MH SF
.475 .550 .541 .477 .585
Bother index vs
PCS BP GH PF RP
.561 .603 .549 .541 .590
MCS VT RE MH SF
.589 .602 .620 .569 .642
BP, Body physical; GH, general health; MCS, mental component summary;
MH, mental health; PCS, physical component summary; PF, physical
functioning; RE, role emotional; RP, role physical; SF, social functioning;
VT, vitality.
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tissue injuries (all P > .05). There was a trend toward worse
scores in the presence of nerve injury in both Dysfunction
and Bother indices (P ¼ .075 and .076, respectively).
Content validity. The mean SMFA-DI was 24.8 6
15.2. Scores ranged from 0 to 78 with a kurtosis and skew
of 0.42 and 0.60, respectively. The ﬂoor and ceiling effects
were 1.2% and 0%, respectively. In comparison, the mean
SMFA-BI was 29.4 6 20.2. Scores ranged from 0 to 96,
with kurtosis and skewness values of 0.58 and 0.15,
respectively. The respective ﬂoor and ceiling effects were
4.3% and 0%. Whereas one subject (0.6%) did not respond
with answers to the SMFA-BI portion of the survey, there
was a 0% nonresponse for the SMFA-DI portion.
Construct validity. Correlations between reported
SMFA-DI and SMFA-BI scores and the SF-36 scales are
detailed in Table II. The SMFA-DI score inversely corre-
lated most with the physical scales and associated compo-
nent summary score. Represented graphically in Fig 2, A,
an r value of 0.636 was indicative of a moderate inverse
correlation. Conversely, the SMFA-BI score inversely
correlated most with the mental scales and component
summary score. Similarly, a correlation coefﬁcient
of 0.589 was also considered a moderate inverse linear
correlation (Fig 2, B).
Criterion validity. Of patients considered disabled,
per Medicare Part A qualiﬁcations, both the SF-36
component scores and SMFA indices demonstrated
poorer outcomes compared with those not qualifying for
disability (Table III, A). The SMFA-DI demonstrated the
largest disparity, with average scores of 33.3 6 16.2 vs
22.3 6 14.2 in those considered disabled and nondisabled,
respectively (P < .001).
Comparison of scores between those nonseverely
injured and those considered major traumas/severely
injured on the basis of overall ISS (score # 15 vs > 15)
demonstrated no signiﬁcant differences between either
SF-36 component scores or SMFA indices (Table III, B).
However, as demonstrated in Table III, C, on comparison
of patients without and with severe limb-speciﬁc injury
scores (MESS < 7 vs $ 7, respectively), only the SMFAindices demonstrated signiﬁcant differences in scores,
each indicative of poorer outcomes (SMFA-DI: 31.5 6
15.7 vs 23.8 6 14.9, and SMFA-BI: 38.0 6 20.2 vs
28.0 6 19.8; both P < .05).
DISCUSSION
SMFA. The SMFA, initially developed by Swiontkow-
ski et al in 1999, has since been implemented in a wide
range of musculoskeletal disease and pathologic states and
has undergone multiple cross-cultural adaptations.14,18-21
Whereas the initial target population of the SMFA
included those with extremity musculoskeletal disease,
there is clear theoretical translational potential in patients
with extremity vascular injuries. There exists a unique op-
portunity in military medicine to evaluate this unique
cohort of patients. The validation and use of a limb-speciﬁc
quality of life survey can help study and guide management
of this traditionally morbid injury pattern. Validity, or
the “degree to which a health-related patient-reported
Fig 2. A, Scatter plot and linear correlation of 36-Item Short Form Health Survey (SF-36) physical component
summary vs Short Musculoskeletal Function Assessment Dysfunction Index (SMFA-DI) (r ¼ 0.636; P < .001). B,
Scatter plot and linear correlation of SF-36 mental component summary vs Short Musculoskeletal Function Assessment
Bother Index (SMFA-BI) (r ¼ 0.589; P < .001).
Table III. A, Score comparisons between disabled and nondisabled patients (as deﬁned by Medicare Part A qualiﬁcation)
Survey Disabled (n ¼ 38) Nondisabled (n ¼ 119) Mean difference (95% CI) P value
SF-36 PCS 40.9 6 7.9 44.2 6 9.7 3.4 (0.3-6.5) .034
SF-36 MCS 41.8 6 13.3 48.0 6 12.0 6.2 (1.4-11.1) .012
SMFA-DI 33.3 6 16.2 22.3 6 14.2 11.0 (16.8 to 5.1) <.001
SMFA-BI 37.2 6 18.9 26.6 6 20.0 10.6 (17.7 to 3.4) .004
CI, Conﬁdence interval;MCS, mental component summary; PCS, physical component summary; SF-36, 36-Item Short Form Health Survey; SMFA-BI, Short
Musculoskeletal Function Assessment Bother Index; SMFA-DI, Short Musculoskeletal Function Assessment Dysfunction Index.
Table III. B, Score comparisons between severe (ISS > 15) and nonsevere (ISS # 15) overall injury scores
Survey Severely injured (ISS > 15; n ¼ 46) Nonseverely injured (ISS # 15; n ¼ 117) Mean difference (95% CI) P value
SF-36 PCS 43.0 6 8.4 43.7 6 9.5 0.7 (2.3 to 3.7) .663
SF-36 MCS 46.7 6 11.4 46.0 6 13.3 0.6 (4.8 to 3.5) .767
SMFA-DI 24.2 6 13.7 25.0 6 15.8 0.8 (4.1 to 5.8) .742
SMFA-BI 27.5 6 17.2 29.9 6 21.1 2.4 (4.0 to 8.7) .461
CI, Conﬁdence interval; ISS, Injury Severity Score; MCS, mental component summary; PCS, physical component summary; SF-36, 36-Item Short Form
Health Survey; SMFA-BI, Short Musculoskeletal Function Assessment Bother Index; SMFA-DI, Short Musculoskeletal Function Assessment Dysfunction
Index.
Table III. C, Score comparisons between severe (MESS $ 7) and nonsevere (MESS < 7) limb injury scores
Survey Mangled extremity (MESS $ 7; n ¼ 24) Nonmangled extremity (MESS < 7; n ¼ 140) Mean difference (95% CI) P value
SF-36 PCS 41.1 6 8.9 43.8 6 9.3 2.7 (1.3 to 6.7) .180
SF-36 MCS 45.0 6 12.4 46.5 6 12.9 1.5 (4.1 to 7.1) .583
SMFA-DI 31.5 6 15.7 23.8 6 14.9 7.8 (14.8 to 0.8) .031
SMFA-BI 38.0 6 20.2 28.0 6 19.8 10.0 (19.1 to 0.9) .032
CI, Conﬁdence interval; MCS, mental component summary; MESS, Mangled Extremity Severity Score; PCS, physical component summary; SF-36, 36-Item
Short Form Health Survey; SMFA-BI, Short Musculoskeletal Function Assessment Bother Index; SMFA-DI, Short Musculoskeletal Function Assessment
Dysfunction Index.
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measure,” in this cohort has been assessed across its
fundamental properties of content, construct, and criterion
validity.22
Content validity. Content validity is the “degree to
which a health-related patient-reported outcome instru-
ment is an adequate reﬂection of the construct to be
measured.”21 The most important aspect contributing tothe content validity is the degree to which the measure-
ment instrument matches the target population.23 All
questions of the SMFA are demographically and clinically
relevant to patients with extremity vascular injuries.
Expectedly, relying on face validity in this manner is often
purely a subjective measure of content. Therefore, score
distribution characteristics can be employed as surrogates
to evaluate the appropriateness of survey items.14,23 As
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pected with limited ﬂoor/ceiling effects and nonresponse
rates. Whereas a ﬂoor/ceiling effect is typically deﬁned as
15% of highest and lowest possible scores, respectively,
values of <5% are considered favorable.14,24,25 As
demonstrated, content validity of the SMFA was present in
this cohort of patients with extremity vascular injuries. The
SMFA-DI encompassed a wide range of scores with little
skew, limited ceiling and ﬂoor effects, and 0% nonresponse
rates. The SMFA-BI demonstrated similar results, although
with slightly higher but acceptable ﬂoor effects and
broadened kurtosis value.
Construct validity. Construct validity is the “degree
to which the scores of a health-related patient-reported
outcome instrument are consistent with other hypotheses
(ie, relationship to scores of other [established] in-
struments) based on the assumption that the instrument
validly measures the construct to be measured.”22
Convergent construct validity was evaluated by compari-
son of the SMFA to an established generic quality of life
survey (ie, SF-36). The SF-36 has been validated in a wide
range of disease and postinjury states and has also been
described previously in this particular patient cohort to
effectively distinguish between those with favorable and
unfavorable outcomes.9 In comparing the SMFA indices to
the SF-36 subscale scores, there were predominantly
moderate correlations (deﬁned as 50%-75% correlation).23
This correlation was most pronounced between the phys-
ical component summary score of the SF-36 and the
Dysfunction Index of the SMFA (r ¼ 0.636) and the
mental component summary score of the SF-36 and the
Bother Index of the SMFA (r ¼ 0.589). Previous studies,
including the initial validation of the SMFA, have evaluated
the relationship between the SMFA and SF-36 in a wide
range of orthopedic and rheumatologic pathologic states,
all demonstrating similarly moderate to strong correlation
coefﬁcients ranging from 0.47 to 0.81.14,26
Criterion validity. Criterion validity is the “degree to
which the scores of a health-related patient-reported
outcome instrument are an adequate reﬂection of a “gold
standard” [as measured by concurrent or predictive val-
idity].”22 Whereas there exists no current gold standard of
evaluating a patient’s perceived limb dysfunction, clinically
relevant substitutes include objective injury severity scoring
(concurrent) and disability qualiﬁcations (predictive).
Comparison between those who were considered to have
severe or mangled extremities and those with less severe
injuries (MESS $7 and <7, respectively), the SMFA-DI
and SMFA-BI demonstrated improved discriminative
capability compared with the SF-36. Similar ﬁndings were
demonstrated in comparison between those patients who
qualiﬁed for disability (as determined by Medicare Part A
eligibility) and those who did not.
As demonstrated, neither the SMFA nor the SF-36 was
able to demonstrate signiﬁcant score differences between
those who were considered to have severe overall injuries
(ISS > 15) and those who were not (ISS # 15). One
may infer that a higher global injury severity wouldtranslate into poorer outcomes. Whereas the ISS may be
useful in evaluating a patient’s initial mortality associated
with a particular injury pattern, consideration of potential
confounding variables should be made in applying any pre-
dictive value to long-term morbidity. First, the ISS con-
siders multiple organ systems in computing a ﬁnal ISS
score. Severe injuries, although conferring similar effects
on initial survival, often have different long-term sequelae
affecting a patient’s long-term quality of life. For example,
splenic lacerations and severely mangled extremities,
although both life-threatening on initial presentation,
have signiﬁcantly different long-term outcomes. Second,
the ISS is a compounded calculation from multiple abbre-
viated injury scores. As such, recording errors become
compounded as well. Last, the conventional ISS cutoff
score of 15 may be overly sensitive, capturing patients
with more moderate injuries and improved recovery and
long-term outcomes. These confounders may result in
the inability of the SMFA or SF-36 to delineate those
with truly severe and morbid injuries based on an ISS score
of 16 or more.
Limitations. Several limitations of this study warrant
mention. There is signiﬁcant heterogeneity within the
cohort of patients examined. Whereas all patients incurred
signiﬁcant extremity vascular injuries, all requiring surgical
intervention (ie, operative exploration with ligation or
repair), certain injury patterns have differing potential for
long-term dysfunction or disability. Nevertheless, hetero-
geneity limits the purity of application to speciﬁc injury
patterns. Possible type II errors may exist, particularly in
evaluating the criterion validity of the SMFA. Inclusion of
all extremity vascular injuries into a single cohort allows
subsequent broader application.
Primary and secondary/delayed amputees were
excluded from analysis. The military experience with ampu-
tation and limb salvage (in the setting of severe orthopedic
injuries) has been described elsewhere.27 Inherently, there
exist many complex and potentially confounding variables
within this demographic that can signiﬁcantly affect out-
comes and analysis when considered as a total group.
Conceivably, quality of life scores can be inﬂuenced by fac-
tors such as time to secondary amputation, level of ampu-
tation, type/capability of prosthesis, ancillary support
(professional and family), and other factors. As demon-
strated by Doukas et al, patients undergoing amputation
appeared to even have less dysfunction compared with
limb salvage, although the authors do acknowledge a large
potential selection bias.27 Additional and directed investi-
gation in the outcomes of this unique patient population
is warranted once patient accrual has been accomplished.
Whereas these results help validate the use of the
SMFA in the setting of extremity vascular injuries, no
data currently exist to examine the reliability or responsive-
ness of the SMFA. The trauma population has several prac-
tical limitations in the ability to assess a patient’s well-being
and limb functionality in a preinjury state. In addition,
long-term evaluation of this injury pattern by objective
clinical tests of limb dysfunction is often logistically
JOURNAL OF VASCULAR SURGERY
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term clinical surveillance of extremity vascular injuries.
This study is also survey based and has additional
limitations to be considered. As with many studies of
this nature, there was signiﬁcant overall nonresponse.
Whereas effort was made to limit this by offering multi-
ple modalities of survey fulﬁllment, scheduled reminders,
and available staff for questions and concerns, the study
experienced approximately 76% nonresponse rate. Under-
standably, this lends results to a possible selection bias as
many nonresponders may also be outliers, thus inﬂu-
encing both ceiling and ﬂoor effects. Although other
studies cross-validating the SMFA quote higher return
rates, they are often smaller or with signiﬁcantly shorter
follow-up.14,18-21,26,28-31
CONCLUSIONS
Use of the SMFA is valid in those with extremity
vascular injuries. Across all facets of survey validity, the
SMFA-DI in particular was best able to describe all aspects
of a patient’s limb dysfunction and to correlate with estab-
lished quality of life surveys, and it was better able to
discriminate patients by means of external indicators of
limb injury severity. The SMFA should be considered an
adjunctive tool in evaluating patient-based outcomes after
combat-related extremity vascular injuries.
The authors acknowledge Joint Theater Trauma Reg-
istry (JTTR) and Patient Administration Systems and
Biostatistics Activity (PASBA) for providing data for this
study.
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